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We report on five consecutive sibs three with fatal renal-hepatic-
pancreatic dysplastic (RHPD) syndrome and two pregnancies
ending in early abortion. Three of the fetuses reached term and
two survived for 15 and58days. They haddiffusely cystic kidneys
with absence of the distal collecting tubules, hepatic fibrosis, bile
duct paucity, and pancreatic fibrosis with irregularly dilated
ducts. These findings correspond to many of those reported by
Ivemark et al. [Ivemark et al. (1959);ActaPaediat Scand48: 1–11]
as part of the RHPD syndrome. There are several notable differ-
ences in this family: one patient had hypocalvaria and a choroid
plexus cyst at the right foramen of Luschka, multiple bone
abnormalities including widened growth plates and abnormal
development of the trabeculae of the ribs, “handle-bar” clavicles,
wedgedefects of the inferiormarginof several thoracic vertebrae;
the second patient had hypocalvaria and abnormally developed
brain with bilateral exposure of the insulae; and a third patient
had anencephaly. Mutational analysis of the two who survived
beyond post-delivery demonstrated compound heterozygous
novel frameshift mutations in the nephronophthisis type 3
gene (NPHP3).  2013 Wiley Periodicals, Inc.
Key words: renal-hepatic-pancreatic dysplasia; nephronophthi-
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INTRODUCTION
Renal-hepatic-pancreatic dysplasia (RHPD) was described in
sibs by Ivemark et al. [1959] but is now known to occur as a
component of many other well-defined syndromes such as the
Zellweger, Meckel, Jeune, Elejalde, and Saldino-Noonan chon-
drodysplasias, trisomies 9 and 13, and glutaric aciduria II [Ive-
mark et al., 1959; Hunter et al., 1991]. RHPD syndrome is an
autosomal recessive trait and many patients present in utero
with oligohydramnios. The kidneys may be dysplastic with
peripheral cortical cysts, primitive collecting ducts, glomerular
cysts, and metaplastic cartilage [Bernstein et al., 1987]. There is
fibrosis of liver and pancreas. Most patients die neonatally of
respiratory insufficiency. RHPD is also known as Ivemark II
syndrome and has been regarded as distinct from Ivemark I
syndrome which comprises heterotaxy, poly- or asplenia and
congenital cardiac anomalies. Recently, RHPD was determined
to be caused by loss of NPHP3 gene function [Bergmann
et al., 2008]. Skeletal and central nervous system (CNS) abnor-
malities were reported rarely, and anencephaly has not been
reported in any documented case of RHPD or NPHP3 muta-
tions. The purpose of this report is to broaden known range of
RHPD due to NPHP3 mutations to include skeletal anomalies
and anencephaly.
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CLINICAL REPORTS
Patient 1
Amale infant was born at 38weeks gestation to a 27-year-oldG2 P1
mother. Antenatal ultrasound examination at 20 weeks showed
“polycystic” kidneys. Oligohydramnios was noted at a follow-up
ultrasound examination and a tentative diagnosis was made of
autosomal recessive polycystic kidney disease. The family history
was negative for renal diseases or fetal or neonatal death and there
was no history of consanguinity or prenatal exposure to alcohol,
drugs, or medications including angiotensin-converting-enzyme
inhibitors or non-steroidal anti-inflammatory drugs. The infant
was born normally. Birth weight was 2.21 kg; placenta and umbili-
cal cord were normal. In the delivery room he was in severe
respiratory distress andwas intubated andmechanically ventilated.
A chest radiograph showed severe pulmonaryhypoplasia and abell-
shaped rib cage. He had large anterior and posterior fontanelles,
wide cranial sutures, Potter sequence, normal heart, abdomen, and
male external genitalia. At 3 hr of life the oxygen saturation acutely
decreased from100%to20%andchest transillumination revealed a
spontaneous left pneumothorax and a chest tube was inserted.
Laboratory studies showed normal serum electrolyte concen-
trations, BUN 9 mg/dl, and serum creatinine concentration
0.9 mg/dl. Results of cranial ultrasound examination were normal.
A repeat chest radiograph showed fused vertebrae. During the first
12 hr of life, he excreted 1 ml of urine. He had hypotension,
episodic oxygen desaturations, pulmonary hypertension and was
treatedwith nitric oxide, dopamine, dobutamine, and epinephrine.
Renal ultrasound studies revealed slightly enlarged kidneys (4.4 and
4.7 cm), a 5 mm cyst in the right kidney, bilaterally increased
echogenicity, lack of corticomedullary differentiation, a dilated
left renal pelvis, and no urine in the bladder. On the 4th day the
serum creatinine concentration was 4.1 mg/dl and peritoneal
dialysis was started. He had a persistent transfusion-dependent
anemia that requiredmultiple blood transfusions. The liver enzyme
levels remained normal. On the 10th day a cranial ultrasound
examination showed a parietal intraparenchymal hemorrhage in
the right middle cerebral artery distribution. An electroencephalo-
gram showed bilateral moderately severe encephalopathy. On day
15, support was withdrawn with parental consent because of sepsis,
a deteriorating clinical status, and severe pulmonary hypoplasia.
Patient 2
A stillborn anencephalic female was delivered at 42 weeks weighing
1.1 kg.
Patient 3
A male infant was born at 36 weeks of gestation. A prenatal
ultrasound study at 17 weeks of gestation showed bilateral renal
cystic dysplasia and oligohydramnios. Due to the anomalies noted
in the previous pregnancies a fetal MRI was performed at 22 weeks
of gestation. It demonstrated large cystic kidneys and a very small
amount of amniotic fluid. There was no history of prenatal expo-
sure to alcohol, drugs, or medications.
Delivery was by elective cesarean because of the critically low
amniotic fluid volume. Birthweightwas 2.605 kg. The placenta and
umbilical cord were normal. He had severe respiratory distress and
bradycardia andwas intubated andmechanically ventilated.A chest
radiograph documented small hypoplastic lungs with normal ribs
and vertebrae. Results of a cranial ultrasound examination was
normal. He remained persistently hypotensive, became acutely
hypoxic, and a right-sided pneumothorax was diagnosed. A chest
tube was inserted, and he was placed on an oscillating ventilator
with nitric oxide infusion.
He had a large anterior fontanelle, wide cranial sutures, Potter
sequence, and severe contractures. Heart, abdomen and genial
examinations were normal. Initial serum concentrations were
sodium 129 meq/L, bicarbonate 13 meq/L, calcium 6.2 meq/L;
serum creatinine 1.3 mg/dl and BUN 21 mg/dl. An abdominal
ultrasound study showed a normal-sized liver with no intrahepatic
ductal dilation, a 1 cm  9 cm right hepatic lobe cyst, and an
enlarged 4 mm common bile duct. The pancreas was normal-sized
(1.1 cm  0.9 cm  0.8 cm) without cysts. Persistent anuria
caused progressive anasarca. The pulmonary edema rendered
him more difficult to oxygenate. Peritoneal dialysis (PD) was
started on the 11th day.
The cardio-respiratory instability and hypotension persisted
over the next 2 months. The course was complicated by: recurrent
pneumothoraces, pulmonary hypertension, marked right ventric-
ular hypertrophy and dilation, a moderate patent foramen ovalum
with bi-directional flow, a small patent ductus with right-to-left
shunting, and transfusion-dependent anemia. There was severe
hepatic dysfunction with persistent hypoalbuminemia and direct
hyperbilirubinemia but the liver enzyme levels remained normal.
Evidenceof pancreatic dysfunctionappearedon the39thdayandan
insulin infusion was initiated to treat hyperglycemia, which even-
tually resolved over 6 days. The peritoneal dialysis was complicated
by leakage and infectionwith coagulase-negativeStaphylococcus.He
had a leukemoid-like reaction with a white blood cell count as high
as 80,000 cells/cm (60% segmented neutrophils, 14% bands, 10%
metamyelocytes, 1% myelocytes). The white blood cell count
gradually normalized over several weeks. On the 57th day he began
to have multiple desaturations that resulted in a prolonged bra-
dycardic and hypotensive episode. A chest roentgenogram at that
time showed complete right upper lobe atelectasis. The patient
recovered from the cardiopulmonary arrest after vigorous manual
ventilation. On the 58th day the parents elected to withdraw
ventilatory support.
Family History
The mother had had two miscarriages. One fetus died in utero at
10 weeks. The chromosomes of this fetus were normal. The second
fetus died at 15 weeks in utero and had enlarged kidneys at 14 1/2
weeks. Over the last 12 weeks of gestation, the mother was given
nine intra-amniotic normal saline infusions. During one of the
infusions the umbilical cord was punctured accidentally and cells
were obtained for chromosomal analysis; this showed a normal 46,
XY karyotype.
Pathology
Patient 1. The anterior fontanellemeasured 4 cm  3 cm and
the posterior fontanelle 3 cm  3 cm. The sagittal, metopic, and
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lambdoidal sutures averaged 1 cm in width. The calvarial bones
were present as irregular islands of ossification with irregularly
jagged or feathered edges and the skull was mainly membranous
fontanelle. There was clinodactyly of the fifth fingers. Rib sections
showed widening of the growth plate with retention of trabecular
cartilage core for many centimeters. Additional skeletal abnormal-
ities included “handle-bar” clavicles, short ribs, and wedge defects
of the inferior margin of several thoracic vertebrae.
The total of the kidneys was 22.5 g (normal ¼ 27 g). The left
ureteropelvic junction was obstructed and the parenchyma of both
kidneys was diffusely cystic. Microscopic examination showed no
normal distal collecting tubules and extensive fibrosis and focal
calcifications. The distal tubuleswere immature and surrounded by
mesenchyme. There were scattered cystically dilated ducts and
several larger centrally located cysts in the left kidney. The bladder
was small, thick-walled, contracted, and empty.
The fetus had a choledochal cyst, obstruction of the ampulla of
Vater, extensive hepatocellular and canalicular bile stasis, and fewer
than one bile duct per portal tract. There was extensive interstitial
fibrosis of the pancreas with dilated, irregular ducts, chronic
inflammation and small areas of normal pancreatic tissue. Islet
cells could be only identified by immunohistochemical staining.
The bonemarrow containedmainlymyeloid precursors andmega-
karyocytes andwasmarkedly deficient in erythroidprecursors. Also
there was a right parietal hemorrhagic infarct and a choroid plexus
cyst at the right foramen of Luschka.
Patient 2. The baby was anencephalic. Heart, lungs, liver,
spleen stomach, and small and large intestines were grossly normal.
Therewerenoadrenal glands. Eachkidneyweighed11 gand, on cut
section there were minute cysts up to 0.2 cm in size. The liver was
markedly congested on cut section.Histological sections of the liver
and kidneywere not available. The pancreas was grossly normal but
histological sections demonstrated areas of interstitial fibrosis with
dilated, irregular ducts, and chronic inflammation.
Patient 3. The anterior fontanelle was large with an open
metopic suture. There was a hypocalvarial skull with “feathered”
small skull bones. Growth plates were well-organized and normally
developed.
Both kidneys were normally positioned within the retroperito-
neum, enlarged and diffusely cystic without any recognizable
normal parenchyma. The cysts ranged in size from <0.1 to 0.5–
1.0 cm.
The collecting system was abnormally developed and both
ureters were atretic before they reached the pelvis. The seminal
vesicles were abnormally developed. The testes were small and
incompletely descended (left in inguinal canal, right in upper
scrotum). The epididymides were immature and detached from
the testes.
The liver showed sinusoidal congestion and portal and sinusoi-
dal fibrosis. The common bile duct was blind-ending with a dilated
extrahepatic biliary tree. There was marked hepatocellular and
canalicular cholestasis and hematopoietic activity throughout
the liver. Many small portal tracts only contained small peripheral
ductules and interlobular ducts were absent as demonstrated by
immunostaining for cytokeratin 7. Sections of a 1.0 cm right
hepatic lobe cyst reveal a cavity lined by biliary epithelium. There
was pancreatic fibrosis, which in some areas almost completely
replaced the exocrine elements.Many ductswere dilated andwithin
the areas of fibrosis displayed irregular configurations similar to
that seen in biliary dysgenesis of the liver.
The bonemarrowwas normocellular. Although therewas triline-
agehematopoiesis, therewerenumeroushistiocyteswith evidenceof
hematophagocytosis, confirmed by CD163 immunostaining.
On gross examination the brain was abnormally developed
(weight 379 g, expected 506 g) with bilateral exposure of the
insulae. Microscopic examination was not performed.
Mutational Analysis
We performed mutation analysis of all known NPHP genes
(NPHP1, INVS, NPHP3, NPHP4, IQCB1, CEP290, GLIS2,
RPGRIP1L, NEK8, SDCCAG8, TMEM67, TTC21B, and WDR19)
by applying a novel high-throughput sequencing technique de-
scribed elsewhere [Halbritter et al., 2012]. In brief, we performed
PCR-based 48.48 Access Arraymicrofluidic technology (Fluidigm)
with consecutive next generation sequencing. We applied a primer
multiplexing approach allowing PCR-based amplification of all
exons for 48 DNA samples simultaneously in all 13 known NPHP
genes (NPHP1-13). After amplification followed by indexing of all
patient-derived products with different 10 bp-barcodes in a subse-
quent PCR, 2  150 paired-end sequencing was performed on a
GAIIx instrument (Illumina). Bioinformatics analysis was con-
ducted using CLC-Genomics-Workbench software.
Mutational analysis in Patient 3 uncovered two novel heterozy-
gous frameshift mutations in the NPHP3 gene (c.1206delA, p.
Val403Serfs9; c.3003delT, Phe1001Leufs61). After isolating
DNA from a FFPE-kidney tissue block from Patient 1, we per-
formed segregation analysis using standard Sanger sequencing.
Patient 1 carries both heterozygous NPHP3 mutations as does
his sib (Patient 3), whereas both parents carry only one heterozy-
gousNPHP3mutation. Themother carries the p.Val403Serfs9 and
the father the p.Phe1001Leufs61 frameshift mutation. No addi-
tional mutations were found in any of the other 12 NPHP genes
investigated by high-throughput mutation analysis. Tissue was not
available for genetic testing on the anencephalic stillborn or the two
miscarriages however the presence renal cysts and pancreatic
abnormalities in the stillborn suggests that the same NPHP3
mutations were present.
DISCUSSION
The triad of renal-hepatic-pancreatic dysplasia, described by Ive-
mark et al. [1959] typically includes cystic kidney disease with
fibrosis of the liver and pancreas. The renal lesions in 18 cases of
non-syndromal renal-hepatic-pancreatic dysplasia [Larson
et al., 1995] were characterized by disorganized parenchyma and
dilated immature ducts surrounded by fibromuscular collars in
loose undifferentiated mesenchyme, and were similar to the find-
ings in our patients. Pancreatic findings [Larson et al., 1995]
included duct ectasia, acinar hypoplasia, and fibrosis consistent
with the severe pancreatic dysplasia and fibrosis in our patients
[Larson et al., 1995]. Findings in the liver of our patients were
notable for extrahepatic duct obstruction, choledochal cyst, hepatic
lobe cyst, severe bile stasis, and lack of bile ducts. Most of the
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originally described cases of RHPD had bile duct proliferation and
portal fibrosis as opposed to paucity. Recently, two sibs were
reported with RHPD and NPHP3 mutations; bile duct paucity,
portal fibrosis, and persistence of embryonic bile duct structures in
the ductal plate [Fiskerstrand et al., 2010]. Bile duct proliferation
has been noted in several of the ciliopathies and is commonly
observed in Meckel syndrome which is phenotypically similar to
RHPD and can also be caused by mutations in the NPHP3 gene
[Bergmann et al., 2008]. The hepatic changes are the most
variable aspect of RHPD and range from minor portal expansion
to bile duct dysgenesis [Larson et al., 1995]. Additionally, two of the
four cases reported by Larson et al. had common bile duct cysts
whichmay be similar to the choledochal cyst and right hepatic lobe
cyst noted in our patients.
Ciliopathy describes a group of genetic conditions whose path-
ogenesis results from defective cilia. A number of syndromes that
had been previously loosely associated with shared clinical features
are now grouped under this rubric. Patients these syndromes have
renal cystic and hepatobiliary disease, some have laterality defects
and retinal degeneration and some have had polydactyly. The
ciliopathies include autosomal recessive and dominant polycystic
kidney disease, nephronophthisis, the Meckel, Bardet–Biedl, Jou-
bert, Senior–Loken, Jeune, oro-facial-digital type 1, Ellis-van Cre-
veld, Sensenbrenner, Alstrom syndromes, and Leber congenital
amaurosis.
Nephronophthisis is a groupof autosomal recessive cystic kidney
diseases ranging from lethality in utero to adult-onset of previously
clinically undetected disease. Patients with nephronophthisis pres-
entwith progressive renal failure. At least seventeen differentNPHP
genes (NPHP1-15, AHI1, and CC2D2A) have been determined
[Chaki et al., 2011]. It is now apparent that there may be consider-
able phenotypic overlap resulting from mutations of the different
NPHP genes as well as genes associated with the other ciliopathies.
For example, mutations in the NPHP6 gene were reported in
patients with the nephronophthisis complex, Meckel syndrome,
Bardet–Biedl syndrome, Joubert syndrome, and Senior–Loken
syndrome [Baala et al., 2007; Helou et al., 2007; Leitch
et al., 2008]. Variable expressionwithin and among families further
complicated traditional classifications. Furthermore, apparently
comparable or even identical mutations in the same gene cause
very different phenotypes.
Bergmann et al. [2008] first described two families with RHPD
associated with loss of NPHP3 function and also described two
other familieswith homozygousmutations in theNPHP3 genewith
different clinical phenotypes. One couple had two children with
Meckel syndrome and the other a child with glomerulocystic
kidney disease, congenital hepatic fibrosis, situs inversus, post-axial
polydactyly, and preauricular fistula. They also described hypo-
morphic mutations in the NPHP3 gene associated with either
isolated adolescent-type nephronophthisis, nephronophthisis as-
sociated hepatic fibrosis, or Senior–Loken syndrome [Olbrich
et al., 2003].More recent studies of families withNPHP3mutations
have also shown that CNS abnormalities (cerebellar vermis aplasia,
polymicrogyria, molar tooth sign, intellectual disability), cardiac
anomalies (atrial septal defect, ventricular septal defects, pulmo-
nary valve stenosis), and situs inversus arenotuncommon[Simpson
et al., 2009; Fiskerstrand et al., 2010; Chaki et al., 2011]. It is now
clear that NPHP3 mutations can cause a broad range of early
embryonic patterning defects resulting in phenotypic overlap of
several of the previously described clinical syndromes. Tables I
and II summarize the clinical findings and genetic mutations that
have currently been observed with NPHP3 mutation associated
RHPD.
Skeletal abnormalities are a major manifestation of several of
the ciliopathies including Jeune syndrome (short ribs, hypoplas-
tic iliac wings, “trident” acetabular roofs, and rhizomelic limb
shorteness), Bardet–Biedl syndrome (post-axial polydactyly and
brachydactyly), Ellis van Creveld (short limbs, short ribs, and
post-axial polydactyly), and oro-facial-digital syndrome but have
been rarely reported in association with RHPD. Balci et al. [Balci
et al., 1999, 2000] described three children with cystic dysplasia
of the kidney and pancreas (without hepatic fibrosis or cysts),
situs inversus totalis, and bowing of the lower limbs and clavicles.
Of note, our Patient 1 had “handle-bar” clavicles. Alessandri
et al. [2009] described two children with renal cystic dysplasia,
paucity of bile ducts, situs inversus, and bowing of the femora. As
a result of the RHPD-like phenotype NPHP3 mutational analysis
was performed but did not uncover any abnormalities. This once
again highlights the considerable phenotypic overlap observed in
what is most likely a yet undetected mutation within the
ciliopathy spectrum. Bergmann et al. [2008] described two
sibs with homozygous NPHP3 mutations and the associated
RHPD phenotype from Cameroon. One of the sibs had extreme-
ly large fontanelles and hypocalvaria. To our knowledge this is
the only other report of hypocalvaria in RHPD due to NPHP3
mutations.
Specific CNS abnormalities including cerebellar vermis hypo-
plasia or agenesis (Joubert syndrome, Bardet–Biedl syndrome),
encephalocele (Meckel syndrome, Joubert syndrome), agenesis
of the corpus callosum (oro-facial-digital syndrome), and cystic
brain lesions (oro-facial-digital syndrome) occur in several of
the ciliopathies although not typically in RHPD. More recently it
has also been recognized that NPHP3 mutations can also be
associated with a variety of CNS abnormalities including cere-
bellar vermis aplasia, polymicrogyia, molar tooth sign, and
intellectual disability [Simpson et al., 2009; Fiskerstrand
et al., 2010; Chaki et al., 2011]. To our knowledge, this is the
first report of anencephaly in RHPD or associated with NPHP3
mutations. It is also noteworthy that [Bergmann et al., 2008]
described a child with homozygous NPHP3 mutations and the
associated RHPD phenotype from Cameroon with a cyst on the
floor of the right ventricle and bilateral choroid plexus cysts.
Patient 1 in our sibship also had a choroid plexus cyst at the
right foramen of Luschka. In addition, Patient 3 in our sibship
also had CNS structural abnormalities with a poorly developed
brain and bilateral exposure of the insulae. Similar CNS findings
were described in a child with NPHP3 mutation associated
RHPD and polymicrogyria [Fiskerstrand et al., 2010].
The questions whether heterotaxy-spectrum cardiovascular
disorders (Ivemark I) and RHPD (Ivemark II) are always sepa-
rate entities is not entirely clear. The majority of heterotaxy cases
are still idiopathic but mutations have been identified in more
than 15 genes in individuals with heterotaxy or heterotaxy-
spectrum congenital heart disease. These mutations likely ac-
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count for approximately 15% of heterotaxy-spectrum disorders
[Tariq et al., 2011]. Situs inversus and congenital cardiac abnor-
malities (atrial septal defect, ventricular septal defects, pulmo-
nary valve stenosis, aortic coarctation) also occur in patients
with mutations in the NPHP2 and NPHP3 genes [Chaki
et al., 2011]. In addition, several other ciliopathy-related clinical
phenotypes were previously associated with both situs inversus
(Meckel syndrome, Bardet–Biedl syndrome, Joubert syndrome)
and congenital cardiac defects (Bardet–Biedl syndrome, Ellis-van
Creveld syndrome).
An early report of RPHDdescribed a brother and sisterwho both
died within 24 hr of birth with enlarged polycystic kidneys
[Crawfurd, 1978]. Both children had cystic renal dysplasia. The
pancreas was enlarged, nodular, and cystic in both children. Liver
histology of one infant showed portal fibrosis with bile duct
proliferation. In addition, one had cardiac transposition and
asplenia and the other had hypoplasia of the spleen. In five patients
with RHPD, two had findings of Ivemark I: one patient had
polysplenia and another had situs inversus without cardiac defects
[Bernstein et al., 1987]. A more recent report from Croatia [Krzelj
et al., 2000] describes a newborn infant with aspects of Ivemark I
syndrome and cystic renal dysplasia: there was dextrocardia, trans-
position of the great vessels, stenosis of the pulmonary artery,
common atrioventricular canal, patent ductus arteriosus, asplenia,
and cystic dilated collecting ducts of the kidney. In addition there
are several reports of Ivemark I syndrome associated with pancre-
atic abnormalities including pancreatic agenesis [Konstantinidou
et al., 2008] and a congenital pancreatic cyst [Chahed et al., 2012].
Whether a subset of patients with heterotaxy-spectrum cardiovas-
cular disorders (Ivemark I) are causedbymutations in the spectrum
of ciliopathies remains to be determined.
In summary, we report on a sibship with a compound
heterozygote mutation in NPHP3 and an RHPD phenotype.
This sibship extends the known phenotype of NPHP3 mutation
caused RHPD to include skeletal and CNS anomalies, specifically
anencephaly.
TABLE I. Renal, Hepatic, and Pancreatic Findings in NPHP3 Mutation Associated Renal-Hepatic-Pancreatic-Dysplasia
NPHP3 mutations Renal Hepatic Pancreatic
Fiskerstrand et al. [2010] Homozygous: c.2694-2_2694-1delAG Small Bile duct paucity Enlarged
Patient 1 Deletion of splice acceptor resulting in
premature stop codon
Cystic dysplastic Portal fibrosis Fibrosis
Fiskerstrand et al. [2010] Homozygous: c.2694-2_2694-1delAG Enlarged Bile duct paucity Dysplasia
Patient 2 Deletion of splice acceptor resulting in
premature stop codon
Cystic dysplastic Abnormally branched
medium-size bile ducts
Dysplastic ducts
Bergmann et al. [2008] Homozygous: Enlarged Cysts Unknown
Patient 1 c.1729C to T Multicystic dysplastic
p.Arg577X
Bergmann et al. [2008] Homozygous: Enlarged Ductal plate malformation Cystic
Patient 2 c.1729C to T Multicystic dysplastic
p.Arg577X
Bergmann et al. [2008] Heterozygous: Ductal plate malformation Normal
Patient 3 c.2918G to A Multicystic dysplastic
p.Arg973Gln
c.3340C to T
p.Gln1114X
Bergmann et al. [2008] Heterozygous: Multicystic dysplastic Ductal plate malformation Increased
Patient 4 c.2918G to A echogenicity
p.Arg973Gln
c.3340C to T
p.Gln1114X
Copelovitch et al. [2013] Heterozygous: Cystic dysplastic Bile duct paucity Fibrosis
Patient 1 c.1206delA p.Val403Serfs9 Choledochal cyst Dilated irregular
c.3003delT Phe1001Leufs61 ducts
Copelovitch et al. [2013] Likely Cysts Congestion Fibrosis
Patient 2 Heterozygous: Dilated irregular
c.1206delA p.Val403Serfs9 ducts
c.3003delT Phe1001Leufs61
Copelovitch et al. [2013] Heterozygous: Enlarged Bile duct paucity Fibrosis
Patient 3 c.1206delA p.Val403Serfs9 Cystic dysplastic Portal Dilated irregular
c.3003delT Phe1001Leufs61 Fibrosis ducts
Hepatic lobe cyst
Enlarged common bile
duct
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